# Black Diamond Therapeutics, Inc.: Form SC 13D/A, filed Nov 9, 2023

- Company: [Black Diamond Therapeutics, Inc.](/companies/bdtx.md) (CIK 1701541)
- Form: SC 13D/A
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 9, 2023, 17:24 ET
- Period: not reported
- Accession: 0001193125-23-274632
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701541/000119312523274632/d473224dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701541/000119312523274632/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701541/000119312523274632/d473224dsc13da.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-274632. Last ingested by Listed: Nov 10, 2026, 16:37 ET. No prices; not investment advice.